Eyenuk, Inc. ("Eyenuk" or "Company"), a global artificial intelligence (AI) digital health company and the leader in real-world applications for AI Eye Screeningâ„¢ and AI Predictive Biomarkersâ„¢, today announced it has secured $26 million in a Series A financing round, bringing the Company's total funding to over $43 million.











